PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
04-Apr-2022 Expansion of Elkton, Virginia Manufacturing Facility to Further Increase Merck’s HPV Vaccine Supply and Support Broader and Equitable Access Businesswire
04-Apr-2022 Global Fill Finish Manufacturing Markets Outlook 2021-2022 & 2031 - ResearchAndMarkets.com Businesswire
04-Apr-2022 The Worldwide Generic Drugs Industry is Projected to Reach $507.8 Billion by 2026 - ResearchAndMarkets.com Businesswire
04-Apr-2022 The Worldwide Anesthetic Drugs Industry is Expected to Reach $6.4 Billion by 2027 - ResearchAndMarkets.com Businesswire
04-Apr-2022 Clinical Outcomes Solutions and FingerPost Mark Five Years of Collaboration Dedicated to Informing the COA Competitive Landscape in the Anti-Cancer Therapy Space Newswire
04-Apr-2022 Adaptive Phage Therapeutics Extends Series B to $61 million with Addition of The AMR Action Fund Businesswire
04-Apr-2022  Athersys Reports That Its Partner, HEALIOS K.K., Provides Updates on MultiStem® Clinical Programs in Japan Businesswire
04-Apr-2022 ACRO Marks 20th Anniversary – And Welcomes New Member Businesswire
04-Apr-2022 Venatorx Pharmaceuticals Raises Series C Financing Led by the AMR Action Fund Businesswire
04-Apr-2022 Arrayjet Introduces Mercury Range of Next-Generation Microarray Printers Businesswire
04-Apr-2022 APAC CRISPR Gene Editing Market Research Report 2022 - ResearchAndMarkets.com Businesswire
04-Apr-2022 Stanley Capital-backed portfolio company DSS acquires MyMeds&Me MyMeds&Me
04-Apr-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
04-Apr-2022 U.S. FDA Grants Priority Review to Genentech’s Actemra for the Treatment of COVID-19 in Hospitalized Adults Businesswire
04-Apr-2022 DIAMOND trial: Veltassa® enables patients to achieve long-term potassium control and optimized RAASi therapy Businesswire
04-Apr-2022 New Data for Genentech’s Ocrevus (ocrelizumab) Show Benefit in Disability Progression and Cognitive Decline in Both Secondary Progressive and Primary Progressive Multiple Sclerosis Businesswire
04-Apr-2022 Aelis Farma Reports 2021 Annual Financial Results and Confirms Its 2022 Outlook Businesswire
03-Apr-2022 Bristol Myers Squibb Announces Data from EXPLORER-LTE Demonstrating Sustained Improvements in Clinically Meaningful Cardiovascular Outcomes at Weeks 48 and 84 in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy Receiving Mavacamten Businesswire
03-Apr-2022 Takeda anuncia candidatos ao Conselho de Administração e próxima assembleia dos acionistas Businesswire
02-Apr-2022 Takeda anuncia los candidatos a su Junta Directiva en la próxima asamblea de accionistas Businesswire